Free Newsletter
Euro watchdogs: Sanofi obstructed probe
Apparently it's an antitrust kind of day: The European Commission announced it's investigating Sanofi-Aventis for obstructing its big probe of anticompetitive tactics in the drug industry. Europe's antitrust watchdog was raiding Sanofi's HQ in France when company officials refused to release documents without a search warrant from the French government. European law, however, requires companies to comply with E.C. inspectors.
You'll recall that in January, the E.C.'s antitrust cops raided a number of drugmakers in January, looking for evidence that their behavior in patenting new drugs and suing generics makers may have dampened competition.
- see the E.C.'s release
- get the Dow Jones story for more
Related Articles:
EU commissioner widens pharma probe
EC launches pharma antitrust probe
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





